Healthy U.S. sales of GM trucks enabled General Motors to grow its share of the lucrative full-size pickup truck market to 34.68 percent, an increase of four percentage points over the 30.65 percent seen in Q2 2019. Ford’s F-Series held a 37 percent share, equal to that of the year-ago quarter, while Ram saw its share slide from 28 percent in Q2 2019 to 24 percent in Q2 2020.
Full-Size Pickup Truck Sales - Q2 2020 - USA
|MODEL||Q2 20 / Q2 19||Q2 20||Q2 19||Q2 20 SHARE||Q2 19 SHARE||YTD 20 / YTD 19||YTD 20||YTD 19|
|RAM RAM PICKUP||-34.55%||117,448||179,454||23%||28%||-17.77%||246,253||299,480|
On a combined basis, sales of both full-size GM trucks – the Chevrolet Silverado and GMC Sierra – totaled 176,256 units in Q2 2020, making GM the second most-popular purveyor or full-size pickups. First place was held by Ford, which sold 4,569 more units of its F-Series than GM did of the Silverado and Sierra, while third place went to FCA, whose Ram pickup accounted for 117,448 deliveries. Fourth and fifth place were brought up by the Toyota Tundra and Nissan Titan, respectively.
Silverado, Sierra Sales - Q2 2020 - USA
|MODEL||Q2 20 / Q2 19||Q2 20||Q2 19||YTD 20 / YTD 19||YTD 20||YTD 19|
Another piece of good news for The General is that GM trucks showed the smallest sales declines of all full-size pickup trucks during the second quarter of 2020. Together, the Chevrolet Silverado and GMC Sierra saw sales fall 11.57 percent, compared to a 22.65 percent drop for the Ford F-Series and 34.55 percent for the Ram Pickup. Toyota Tundra sales fell 19 percent while those of the Nissan Titan were down 22 percent.
Overall GM sales fell 34 percent to 492,489 units during the second quarter of 2020 as the Detroit-based automaker and the auto industry at large navigated a precarious landscape riddled by challenges stemming from the COVID-19 pandemic. Automakers faced shortages of key vehicles as production was idled in March until May. Pickup trucks were hit the hardest, creating a scarcity of the popular vehicles. Production resumed on a limited basis in May with new procedures and processes in place designed to keep workers safe and plants operating. The process has not been easy, as COVID-19 cases have been reported in a handful of GM plants around the continent.